by nms-sync | Sep 29, 2021 | News
NMS Group is proud to be named by Pharma Tech Outlook as Top drug discovery and development solution providers in Europe for 2021 and featured in the cover of this special issue.
The annual list showcases companies that are providing cutting-edge drug...
by nms-sync | May 17, 2021 | News
Nerviano, 17 May 2021 The relationship between Accelera and CROss Alliance® started a decade ago and since then we have renewed our collaboration during the years.
Our specializations, preclinical and early phase clinical development respectively, our shared...
Welcome and Check out our new motion picture!
Recent Comments